Integrated in vivo functional screens and multiomics analyses identify α-2,3-sialylation as essential for melanoma maintenance
Praveen Agrawal, Shuhui Chen, Ana de Pablos-Aragoneses, Yellamandayya Vadlamudi, Fatemeh Vand-Rajabpour, Faezeh Jame-Chenarboo, Swarnali Kar, Amanda Flores Yanke, Pietro Berico, Eleazar Vega‐Saenz de Miera, Farbod Darvishian, Iman Osman, Amaia Lujambio, Lara K. Mahal, Eva Hernando
Abstract
Aberrant glycosylation is a hallmark of cancer biology, and altered glycosylation influences multiple facets of melanoma progression. To identify glycosyltransferases, glycans, and glycoproteins essential for melanoma maintenance, we conducted an in vivo growth screen with a pooled short hairpin RNA library of glycosyltransferases, lectin microarray profiling of benign nevus and melanoma samples, and mass spectrometry-based glycoproteomics. We found that α-2,3-sialyltransferases ST3GAL1 and ST3GAL2 and corresponding α-2,3-linked sialosides are up-regulated in melanoma compared to nevi and are essential for melanoma growth. Glycoproteomics revealed that glycoprotein targets of ST3GAL1 and ST3GAL2 are enriched in transmembrane proteins involved in growth signaling, including the amino acid transporter SLC3A2/CD98hc. CD98hc suppression mimicked the effect of ST3GAL1 and ST3GAL2 silencing, inhibiting melanoma cell proliferation. We found that both CD98hc protein stability and its prosurvival effect on melanoma are dependent upon α-2,3-sialylation mediated by ST3GAL1 and ST3GAL2. Our studies reveal α-2,3-sialosides functionally contributing to melanoma maintenance, supporting ST3GAL1 and ST3GAL2 as therapeutic targets in melanoma.